Exact localization of acute thrombi is still a serious problem in the clinical setting. Here we show the feasibility of artefact-free 19F MR-imaging using clinically relevant PFOB-nanoemulsions functionalized with an α2-antiplasmin peptide, specific for early thrombi. Utilizing the isolated CF3-peak of PFOB in combination with a conventional 19F RARE sequence is suitable for specific and artefact-free imaging of acute thrombi in vitro and also in vivo.
This abstract and the presentation materials are available to members only; a login is required.